Registry of extracorporeal life support cases in China

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects data on patients receiving extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), for cardiac and respiratory support. The study aims to evaluate both short-term and long-term outcomes of ECLS in various medical centers across China. It is conducted by the Chinese Society of Extracorporeal Life Support and involves multiple hospitals contributing data to understand the effectiveness and growth of ECLS in the region.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients receiving ECMO for circulatory and/or respiratory support

Exclusion Criteria:

* Refusal of consent

Where it's running

• Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Xiaotong Hou, MD., PhD.
• Email: xt.hou@ccmu.edu.cn
• Phone: 8610 64456631

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prolonged nasogastric ketone infusion for decompensated heart failure

  This will test whether a continuous nasogastric infusion of a ketone (D‑beta‑hydroxybutyrate) can safely reach target blood levels in adults with severely reduced ejection fraction admitted for acute decompensated heart failure or cardiogenic shock.

  Recruiting Phase 4 Institute for Clinical and Experimental Medicine · Prague, Prague · NCT07527156

• Magenta Elevate™ device for cardiogenic shock

  This trial tries the Magenta Elevate™ device to see if it can safely support people with cardiogenic shock caused by left ventricular failure.

  Recruiting at 8 sites Magenta Medical Ltd. · Tbilisi and 7 other locations · NCT07293923

• Initiation and Titration of GDMT with Impella 5.5 in Heart Failure with Cardiogenic Shock

  This study tests a device-plus-drug strategy using the Impella 5.5 alongside optimized guideline-directed medical therapy to see if heart recovery improves in adults with decompensated heart failure and cardiogenic shock.

  Recruiting at 2 sites Abiomed Inc. · Tampa, Florida and 16 other locations · NCT06965504

• Impact of lower vasopressor use on survival in patients with heart failure on ECMO

  This study is testing if using less vasopressor medication can help adults with heart failure on ECMO survive better over 30 days.

  Recruiting Beijing Anzhen Hospital · Beijing, Beijing Municipality · NCT06862700

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing closed-loop synchronization to conventional synchronization in noninvasive ventilation for breathing patients

  This study is testing if a new automatic breathing device helps adults using noninvasive ventilation breathe better compared to standard methods.

  Recruiting Başakşehir Çam & Sakura City Hospital · Izmir · NCT06357780

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.